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ABSTRACT 
Objective: Present study was undertaken to investigate the nephroprotective activity of whole plant ethanol extract of Biophytum sensitivum Linn. 
DC (B. sensitivum; EEBS) on gentamicin induced-nephrotoxicity in Wistar albino rats. 
Methods: Animals were divided into five groups, containing six animals in each. Gentamicin (GM) 100 mg/kg/d; i. p., was given to all groups except 
normal control to induce nephrotoxicity for a period of 8 d in rats. Animals in Group I served as control and Group II as GM-treated or nephrotoxic 
control. Group III received standard quercetin (50 mg/kg; p. o.); group IV received EEBS (250 mg/kg; p. o.) and group V received EEBS (500 mg/kg; 
p. o.), for 8 d. Several renal functional tests and injury markers such as a change in body weight, water intake, urine volume and pH, urinary levels of 
total protein, albumin, sodium, potassium, calcium and magnesium were measured. Different hematological parameters including, red blood cells 
(RBC), hemoglobin (Hb), packed cell volume (PCV), mean corpuscular haemoglobin (MCH), white blood corpuscles (WBC), lymphocyte, monocyte, 
polymorphs and eosinophil were also analyzed. 
Results: The results revealed that co-administration of EEBS at 250 and 500 mg/kg significantly reduced the urinary excretion of total protein 
(4.05±0.04, 3.53±0.05 g/dl), albumin (0.81±0.08, 0.71±0.00 g/dl), calcium (8.05±0.05, 7.81±0.06 mg/dl) and magnesium (0.79±0.05, 0.77±0.06 
mg/dl) respectively. EEBS treatment in group IV and V animals produced a significant increase in body weight (2.58±0.17, 2.52±0.22 g), water 
intake (17.35±0.82, 17.87±0.86 ml/24 h) urine output (7.24±0.15, 7.88±0.08 ml/24 h), compared to animals in group II. Co-therapy with both doses 
of extracts also showed significant increase in RBC (6.85±0.31, 7.10±0.43 million/mm3) Hb (13.96±0.21, 13.83±0.31 g/dl), MCH (20.45±0.49, 
20.67±0.51 pg) and PCV (38.29±0.42, 38.53±0.20%) levels, whereas WBC (8.24±0.21, 8.15±0.10 1X103/mm3
Conclusion: This study substantiated and confirmed the ethnomedical usefulness of B. sensitivum as a nephroprotective and antioxidant agent. 
) and polymorphs (14.19±0.20, 
14.05±0.11%) levels were found to be significantly reduced respectively in animals than those in toxic control group.  
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Gentamicin (GM) is a typical aminoglycoside antibiotic which provides 
an effective treatment against life-threatening gram-negative 
infections [1]. It is still widely used in clinical practice because of its 
low cost and efficacy, even though less nephrotoxic antibiotics are 
available [2]. However, 30% of patients treated with GM, for more 
than 7 d show some signs of nephrotoxicity [3]. Lowering level of red 
blood cells (RBC), hemoglobin (Hb), mean corpuscular haemoglobin 
(MCH), packed cell volume (PCV), lymphocytes in rats treated with the 
nephrotoxic drug may be due to the imbalance between the rate of 
normal production of erythropoietin and their catabolism/ 
destruction. Lowering of RBC count indicated that these nephrotoxic 
drugs might induce a direct toxic effect on red blood cells thereby, 
reducing its lifespan. These deleterious effects perhaps as 
consequence of the generation of reactive oxygen species. It has been 
reported that GM induces apoptosis, necrosis, and oxidative stress due 
to the accumulation of drug at a concentration of 5–50 times higher 
than plasma in the tubular renal cell [4]. Lipid peroxidation (LPO) 
mediated by reactive oxygen species (ROS) has been suggested as a 
causative agent of cell death [5]. GM-induced renal damage is a widely 
used model for inducing nephrotoxicity in experimental animals [6]. 
Medicinal plants have curative properties on drug-induced 
nephrotoxicity due to the presence of various complex chemical 
substances. Ancient literature has prescribed that co-administration of 
various medicinal plants possessing nephroprotective activity along 
with different nephrotoxic agents may attenuate its toxicity [7]. 
Biophytum sensitivum Linn. DC (B. sensitivum; Vernacular names: 
Tamil-Nilaccurunki, Tintaanaalee; Malayalam-Mukkutti; Hindi-Lajalu, 
Lajjaalu, Lakshmana) belongs to family Oxalidaceae [8]. Phytochemical 
investigations of various extracts of B. sensitivum had revealed the 
presence of large amount of phenolic and polyphenolic compounds, 
saponins, polysaccharides, pectin and essential oils. The principle 
bioactive constituents are bioflavonoids like amentoflavone, with trace 
amounts of cupressoflavone, luteolin, isoorientin and isovitexin [9]. It 
has been used as a traditional folk medicine in various ailments. 
Grounded leaves shows diuretic activity and powdered form is 
indicated for urolithiasis [10]. Recently antioxidant [11], antibacterial 
[12], antidiabetic [13], antitumour [14], anti-inflammatory [15] and 
cardio protective activities [16] were reported. Therefore, as the 
search for the nephroprotective drug from natural sources has gained 
immense potential, this study was aimed to investigate the in vivo 
neuroprotective activity of ethanol extract of B. sensitivum (EEBS) in 
GM-induced nephrotoxicity in Wistar albino rats. 
MATERIALS AND METHODS 
Animals 
Adult male albino rats of Wister strain, weighing between 150-200 g 
were housed under standard laboratory condition of 12:12 dark and 
light cycle, 50% humidity and temperature 25±2 °C. They were 
allowed free access to standard commercial rat feed pellets (SAI 
Animal Feed Ltd., Bangalore, India) and were given water ad libitum. 
The animals were acclimatized to laboratory condition for 7 d before 
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the commencement of experiments. Ethical clearance (KMCRET/Ph. 
D/12/2015-16) was obtained from Institutional Animals Ethics 
Committee (IAEC). The rats received human care according to the 
guideline of Committee for the Purpose of Control and Supervision 
of Experiments on Animals (CPCSEA). 
Drugs and chemicals 
Gentamicin was obtained from Central Drug House (CDH), New Delhi, 
India and quercetin from Microlabs (Pondicherry, India). All other 
chemicals and reagents used in this study were of analytical grade. 
Animal grouping 
GM-induced nephrotoxicity model was used to assess the 
nephroprotective activity in albino Wistar rats [17, 18]. Animals 
were divided into 5 groups, designated as Group I, II, III, IV and V, 
containing 6 animals each. Animals in Group I served as control and 
received normal saline for 8 d. GM (100 mg/kg/d; i. p.) 
was administered for a period of 8 d to animals in Group II to V for 
inducing nephrotoxicity. Group II served as GM-treated or 
nephrotoxic control and received vehicle (1% tween 80). Group III 
received standard quercetin (50 mg/kg; p. o.) for 8 d. Group IV 
received EEBS (250 mg/kg; p. o.) and Group V received EEBS (500 
mg/kg; p. o.), for 8 d. 
Plant-source and identification 
The whole plant, B. sensitivum was collected from Shevaroy Hills, 
Salem District, Tamil Nadu, India and was taxonomically identified 
and authenticated by Dr. A. Balasubramanian, Executive Director, 
ABS Botanical conservation, Research and Training Centre, 
Kaaripatti, Salem (Dt.) Tamilnadu (Ref. No-AUT/JKK/095). 
Preparation of plant extract 
The whole plant was washed and shade dried for about 3 w. Dried 
plant was coarsely powdered, sieved (mesh size=40) and stored in 
an air-tight container at room temperature. Powdered plant material 
(500 g) was sequentially extracted with petroleum ether (60-80 °C) 
for defatting and then with 70% ethanol using Soxhlation method. 
The extract was then filtered and evaporated to dryness in a water 
bath. After weighing, the dried extract was stored in air-tight 
container for further use. 
Phytochemical investigation 
The EEBS was tested for the presence of alkaloids, flavonoids, 
phenolic compounds, tannins, glycosides, saponins, terpenoids, 
steroids, protein, carbohydrates and fixed oils using the standard 
procedures [19, 20]. 
Acute toxicity studies 
Acute oral toxicity studies were not performed as studies of 
ethanolic extract of the whole plant B. sensitivum have already been 
reported. The previous study by Anidya et al., [21] used 5000 mg/kg 
dose of EEBS as a higher dose in albino rats. 
Analysis of urine 
Hence, one-tenth of this 
dose, 500 mg/kg (higher dose) and lower dose as 250 mg/kg have 
been selected for the present study. 
At the end of treatment schedule, the animals were housed in 
individual metabolic cages and 24 h urine samples were collected on 
9th
Analysis of blood 
d. Change in body weight, water intake, urine volume and pH 
were recorded. A drop of concentrated hydrochloric acid was added 
to the collected urine and stored at 4 °C. Urine was then analyzed for 
total protein [22], albumin [23], sodium [24], potassium [25], 
calcium [26], and magnesium [27]. 
After collecting the urine, the animals were anaesthetized with ketamine 
HCl and blood was collected from tail vein under mild anesthesia. 
Various haematological parameters including, red blood cells (RBCs), 
hemoglobin (Hb), packed cell volume (PCV), mean corpuscular 
haemoglobin (MCH), white blood corpuscles (WBC), lymphocyte, 
monocyte, polymorphs and eosinophils were also analyzed [28, 29]. 
Histopathological studies 
The right kidney was fixed in 10% neutral buffered formalin, 
processed in a series of graded alcohol and xylene, embedded in 
paraffin wax, sectioned at 5μm and stained with haematoxylin and 
eosin (H and E) for histopathological examination 
Statistical analysis 
The results were expressed as mean±SEM. Statistical significance 
between means was analyzed by one-way analysis of variance 
(ANOVA) followed by “Dunnett’s test.” P values<0.05 were 
considered statistically significant. 
RESULTS 
The yields of petroleum ether and ethanol extracts were 4.92% w/w 
and 12.54% w/w respectively. The preliminary phytochemical 
investigation indicated that EEBS showed the presence of 
carbohydrates, alkaloids, steroids, saponins, proteins, amino acids, 
flavonoids, tannins, phenolic compounds and fixed oils. 
Effect of EEBS on general and urinary parameters of control and 
experimental animals 
Table 1 depicted the effect of EEBS on general and urinary parameters 
of control and experimental animals that were obtained at the end of 
the experiment in each group. Body weight was measured before 
starting the experiment. The animals in the control groups gained 
3.06±0.23 g of body weight, while GM-treated animals (group II) 
gained only 1.50±0.11 g of body weight. Body weight of animals in 
group IV and group V gained 2.58±0.17 g and 2.52±0.22 g respectively. 
24 h urine volume in the GM-treated group was found to be reduced in 
comparison to control group (p<0.01). Supplementation of quercetin 
(50 mg/kg) and EEBS (250 and 500 mg/kg) to GM-treated rats 
significantly increased urine output almost similar to the animals in 
control group. However, water intake was significantly (p<0.05) 
increased only in animals co-administered with 500 mg/kg of EEBS. 
Urinary pH in the GM-treated group was found to be 6.6±0.04 which 
revealed no significant (p>0.05) changes in urinary pH compared to 
animals in other groups (table 1, group II). GM-treated rats showed a 
marked increase in urinary protein excretion 4.52±0.02 g/dl vs 
controls (3.65±0.01 g/dl) and albumin 0.84±0.06 g/dl vs. controls 
(0.77±0.01 g/dl) excretion. Co-treatment with EEBS (250 or 500 
mg/kg) or querticin 50 mg/kg significantly (p<0.01) reduced the 
incidence of proteinuria in rats compared to GM-treated rats (table 1, 
group III, IV, V). Significant (p<0.01) reduction in urinary albumin 
levels were observed only in animals treated with standard or EEBS at 
higher concentration. Urinary excretion of calcium and magnesium 
levels (p<0.01) were found to be much higher in group II animals 
compared to animals in control group. Co-treatment with quercetin or 
EEBS [250 mg/kg and 500 mg/kg] significantly decreased urinary 
calcium (p<0.001) and magnesium (p<0.01) excretion compared to 
GM-treated animals. 
Effect of EEBS on hematological parameters of control and 
experimental animals 
Table 2 demonstrated that Hb, PCV (p<0.001), RBCs and MCH levels 
(p<0.01) were significantly lower in rats treated with GM than those 
in the control group. WBC (p<0.01) and polymorphs (p<0.001) were 
found to be significantly elevated in rats in group II, compared to 
animals in group I. Results revealed that the animals co-treated with 
standard/extract caused a significant (p<0.01) increase in RBCs, Hb 
and MCH level. PCV was found to be increased only in animals co-
treated with quercetin/high dose of EEBS (p<0.01). Total WBC and 
polymorphs were found to be significantly reduced in animals co-
treated with standard/extract (p<0.01). 
Results of histopathological studies 
Histopathological analysis revealed the normal morphology of 
glomeruli, tubules, blood vessels and interstitium of animals in 
control group. However, a photomicrograph of a histological section 
of both cortex and medulla of GM-treated rat kidney showed 
mesangial hypercellularity in the glomerulus, tubular necrosis and 
tubular degeneration. Blood vessels showed congestion whereas 
interstitium showed no significant pathology. Animals treated with 
Abhirama  
Int J Pharm Pharm Sci, Vol 10, Issue 5, 130-135 
 
132 
GM and quercetin showed mild mesangial hyper cellularity in the 
glomerulus and mild congestion in blood vessels. Interstitium and 
tubules showed no significant pathology. Histological section of rat 
kidney (cortex and medulla) treated with low dose of the extract 
(250 mg/kg, b.w.) indicated moderate tubular necrosis, tubular 
degeneration, and cytoplasmic vacuolation in the proximal tubules. 
Glomerulus showed mild mesangial hypercellularity and the 
interstitium showed no significant pathology. Histological section of 
kidney of rat in group V treated with EEBS at a dose of 500 mg/kg 
showed regenerative changes in tubules and glomeruli. Glomeruli 
and interstitium showed normal morphology. Tubules showed no 
significant pathology except mild cytoplasmic vacuolation in tubules. 
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EEBS: Ethanol extract of B. sensitivum, GM: gentamicin, QTN: quercetin. Values are expressed in mean±SEM (n=6), *p<0.05, **p<0.01, ***p<0.001 a-
significant compared with control group, b-significant compared with GM-induced group ns-not significant. 
 






GM 100 mg/kg 
Group III GM+QTN 
50 mg/kg 
Group IV 
GM+EEBS 250 mg/kg 
Group V 
GM+EEBS 500 mg/kg 
RBC (million/mm3 7.35±0.14 ) 6.81±0.31**a 7.22±0.21** 6.85±0.31**b 7.10±0.43**b b 
HB (g/dl) 14.11±0.28 11.76±0.58*** 14.02±0.13**a 13.96±0.21**b 13.83±0.31**b 
PCV (%) 
b 
43.66±0.52 38.27±0.81***a 39.58±0.61** 38.29±0.42b 38.53±0.20**ns 
MCH (pg) 
b 
20.67±0.12 20.19±0.69**a 20.84±0.27** 20.45±0.49**b 20.67±0.51**b 
WBC (1X10
b 
3/mm3 8.22±0.41 ) 8.43±0.33**a 8.21±0.41** 8.24±0.21b 8.15±0.10****b 
Lymphocytes (%) 
b 
60.05±0.01 59.96±0.08 59.97±0.01ns 59.96±0.02ns 59. 96±0.05ns 
Monocytes (%) 
ns 
4.97±0.00 5.00±0. 01 4.96±0.01ns 4.97±0.06ns 4.96±0.06ns 
Polymorphs (%) 
ns 
12.22±0.21 15.84±0.11*** 14.65±0.32**a 14.19±0.20**b 14.05±0.11**b 
Eosinophils (%) 
b 
1.93±0.01 2.02±0.01 1.97±0.08ns 1.97±0.02ns 1.96±0.01ns ns 
EEBS: Ethanol extract of B. sensitivum, GM: gentamicin, QTN: quercetin. Values are expressed in mean±SEM (n=6), *p<0.05, **p<0.01, ***p<0.001 a-








Fig. 1: Histological section of the glomerular and tubular region of kidney stained with haematoxylin and eosin. (A and B) control rat 
showed normal morphology of glomeruli and tubules. (C and D) Rats received GM 100 mg/kg/d (i. p.) for 8 d wit
 
h mesangial 
hypercellularity in the glomerulus, tubular necrosis and tubular degeneration. (EandF) Rats administered with quercetin 50 mg/kg (p. 
o.)+GM showed mild mesangial hypercellularity in glomerulus but tubules showed no significant pathology. (GandH) Rats received EEBS 
at dose of 250 mg/kg (p. o.)+GMshowed mild mesangial hypercellularity in the glomerulus, moderate tubular necrosis, tubular 
degeneration, and cytoplasmic vacuolation. (I and J) Rats received EEBS at a dose of 500 mg/kg (p. o.)+GM showed no significant 
pathology except mild cytoplasmic vacuolation in tubules 
DISCUSSION 
Progressive weight loss of animals in the GM-treated group has been 
closely linked to poor feed or water intake. Urine output was 
significantly reduced in group II animals, however, supplementation 
of EEBS to GM-treated rats significantly improved body weight, 
water intake and urine output. GM-induced kidney injury might alter 
the release of antidiuretic hormone (ADH) or thirst centre activity in 
the cerebral cortex [30]. Usually, the acidity of urine increases 
consistently with the degree of kidney injury [31]. However, in this 
study, there were no significant differences in urinary pH among 
animals in all groups. The incidence of elevated levels of urinary 
excretion of total protein has been suggested as an index of renal 
damage and proximal tubular dysfunction [32]. In this study, the 
elevated levels of urinary protein or albumin were significantly 
reduced by EEBS treatment in rats co-administered with GM. These 
observations indicated a protective role of EEBS in GM-induced 
nephrotoxicity. 
GM-induced nephrotoxicity has been mainly associated with fall in 
glomerular filtration rate. Disturbance of electrolyte homeostasis is 
a less well-documented side-effect of aminoglycoside therapy. GM-
induced a rise in urinary excretion of sodium and potassium has 
been reported previously [33]. Foster et al.,[34] reported that acute 
GM infusion into rats induced hypercalciuria and hypermagnesemia. 
In this study, co-administration of EEBS showed a significant 
reduction in calcium and magnesium excretion, but there were no 
significant differences in the urinary level of sodium and potassium 
excretion compared to the GM-treated group. Thus, prevention of 
hypercalciuric and hypermagnesemic effect may probably be 
attributed to the protective effect of EEBS in GM-induced nephron-
toxicity. 
Determination of haematological parameters are considered as the 
earliest indicator of the deleterious effect produced by the 
nephrotoxic drug and its metabolite [35]. Exposure of human body 
to toxic substances may affect multiple organ systems and cause 
morphological, biochemical and physiological changes, including 
impaired kidney function and haematological disorders [36-38]. 
Hematopoietic system is the main target of some drug which 
adversely affects heme synthesis enzymes, the normal production 
rate of erythropoietin, normal range, morphology and distribution of 
various blood cells [39, 40]. Toxic drugs damage erythrocyte and 
affect its oxygen-carrying capacity thereby increase the risk of 
developing hypertension and cardiac arrest [41]. Factors 
contributing to the pathogenesis of anaemia include shortened RBC 
survival, marrow suppression by uraemic toxins, iron or folate 
deficiency. Damage of peritubular cells especially due to the 
exposure to toxins resulted in inadequate secretion of 
erythropoietin. In this study, it was observed that haematological 
parameters were significantly affected due to the administration of 
GM. Fall in the haemoglobin content, red blood cells counts count, 
packed cell volume, mean corpuscular hemoglobin level and 
elevation of white blood cells count and polymorphs were observed 
in animals in the toxic control group.  
These effects may cause defective hematopoiesis, anaemia and 
weakness in experimental rats. Overall, results of this study 
suggested that the animals co-administered with standard/extract 
showed a significant reversal in the haematological parameters that 
observed in animals in the toxic control group and showed an 
improvement in hematological status. Ebtihal et al., [42] narrated 
that that concurrent administration of Acacia senegal with GM 
reversed the reduction in Hb, RBC, PCV that observed in toxic 
control animals. 
Nephrotoxicity in experimental animals can be confirmed by 
evaluating pathological symptoms such as tubular degeneration, 
desquamation, necrosis, intertubular haemorrhage, the presence 
of hyaline casts in tubules, congestion and swelling in 
glomerulus [43]. In this study, treatment with GM caused acute 
renal damages which were evident by marked mesangial 
hypercellularity in glomerulus, focal tubular epithelial loss and 
blood vessel congestion, compared to animals in control group.` 
These changes were reduced in EEBS-treated groups which were 
evident from mild cytoplasmic vacuolation in the proximal 
tubules, thus showing a protective effect of the drug. It was 
observed that amelioration of GM-induced renal injury was more 
insightful in rats treated with 500 mg/kg of EEBS. 
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The phytochemical screening of EEBS revealed the presence of 
carbohydrates, alkaloids, steroids, saponins, proteins, amino acids, 
flavonoids, tannins, phenolic compounds and fixed oils. EEBS treatment 
restored GM-induced proteinuria, albuminuria and disturbances in 
urinary level of calcium and magnesium, body weight, water intake and 
urine output. Co-therapy with EEBS showed a significant reversal in the 
hematological parameters that were observed in animals in the toxic 
control group and exhibited improvement in hematological status. 
Histopathological examination of kidneys substantiated the results 
obtained from in vivo evaluation of nephroprotective activity in animals. 
These observations indicated that the nephroprotective activity of the 
extract might be due to the presence of phenolic and flavonoid content 
and its antioxidant nature. However, further studies are required to 
isolate the phytoconsitutents and confirm these findings. 
CONCLUSION 
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